Israel Englander Biovie Inc. Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$0.53 - $1.89 $12,621 - $45,008
-23,814 Reduced 64.43%
13,148 $6,000
Q4 2023

Feb 14, 2024
SELL
$1.22 - $5.24 $363,262 - $1.56 Million
-297,756 Reduced 88.96%
36,962 $46,000
Q2 2023

Aug 14, 2023
BUY
$4.09 - $8.29 $1.23 Million - $2.49 Million
300,227 Added 870.45%
334,718 $1.44 Million
Q1 2023

May 15, 2023
SELL
$4.89 - $10.53 $448,603 - $966,011
-91,739 Reduced 72.68%
34,491 $279,000
Q4 2022

Feb 14, 2023
BUY
$3.86 - $42.0 $487,247 - $5.3 Million
126,230 New
126,230 $981,000

Others Institutions Holding BIVI

# of Institutions
5
Shares Held
340K
Call Options Held
0
Put Options Held
0
View Full List

About BIOVIE INC.

BIVI Quotes by TradingView
  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $86.3M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email